Ennis (EBF) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts EBF Hot Sheet
Price: $21.96 --0%
Financial Fact:
Total other income (expense): 810K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Total other income (expense): 810K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Ennis (NYSE: EBF) reported Q1 EPS of $0.31, $0.06 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $141.2 million versus the consensus estimate of $146 million.
For earnings history and earnings-related data on Ennis (EBF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Telesat Corporation (TSAT) Misses Q2 EPS by 1006c
- ADC Therapeutics SA (ADCT) Tops Q2 EPS by 11c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
